22 research outputs found
Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases
The clinical and epidemiological characteristics of 111 consecutive cases of visceral leishmaniasis identified from 1980 to 2000 in a Sicilian pediatric hospital were analyzed retrospectively. The mean age of the patients was 1.7 years. All children were HIV negative, but 15% were severely malnourished. Fever and splenomegaly were present in all cases and hepatomegaly in 101 (90.1%) cases. Thrombocytopenia and anemia were both observed in 78 (70.2%) cases and leukopenia in 47 (42.3%) cases. A bone marrow aspirate was obtained in all cases; Leishmania amastigotes were detected in 89 (80.2%) cases. Initial treatment consisted of meglumine antimoniate in 99 (89.2%) patients and amphotericin B in 12 (10.8%) patients. Only two children treated with meglumine antimoniate relapsed. The findings highlight the differences between the cases of visceral leishmaniasis observed in the Mediterranean basin and those observed in other regions. The use of the term "Mediterranean visceral leishmaniasis", rather than the term "kala-azar", is proposed for cases observed in the Mediterranean are
Treatment of human brucellosis with rifampin plus minocycline
In order to evaluate the efficacy and tolerability of a high intravenous dose of rifampin plus oral minocycline (administered daily for 3 weeks) for the treatment of acute brucellosis, we retrospectively reviewed the outcome of 239 consecutive patients (135 adults and 104 children) diagnosed and treated over a 17-year period in Italy. The combination used resulted in 100% response and a relapse rate lower than 2%. Fifty-two (30 adults and 22 children) (29.8%) complained of mild adverse effects including an increase in aspartate aminotransferase (>250 IU) observed in 12 cases and considered related to rifampin and in 11 cases a reversible hyperpigmentation of the tongue attributed to minocycline. A randomized prospective comparative study should be performed to confirm our encouraging result
Efficacy and safety of clarithromycin as treatment for Mediterranean spotted fever in children: a randomized controlled trial
Fifty-one children with Mediterranean spotted fever (MSF) were randomized to receive either clarithromycin, 15 mg/kg/day orally in 2 divided doses, or chloramphenicol, 50 mg/kg/day orally in 4 divided doses, for 7 days. Mean time to defervescence was 36.7 h in the clarithromycin group and 47.1 h in the chloramphenicol group (P=.047). Clarithromycin could be an acceptable therapeutic alternative to chloramphenicol and to tetracyclines for children aged <8 years with MS
Polymerase chain reaction in the diagnosis and prognosis of Mediterranean visceral leishmaniasis in immunocompetent children
OBJECTIVE:
To assess the usefulness of a polymerase chain reaction (PCR) assay amplifying the small subunit rRNA coding region of Leishmania species performed on peripheral blood (PB) and bone marrow (BM) aspirates for the diagnosis and follow-up of visceral leishmaniasis (VL) in children living in the Mediterranean basin.
DESIGN:
A prospective study was conducted on children consecutively hospitalized over a 1-year period at our Infectious Diseases Department in Sicily (Italy) presenting with fever, hepatosplenomegaly, and/or pancytopenia and a positive Leishmania serology (> or =1:40).
RESULTS:
Among the 14 patients hospitalized with signs and symptoms suggestive of the disease and a positive serology, we identified 10 cases of Mediterranean VL. PCR performed on PB and BM aspirates was positive in all cases and concordant with microscopy and/or culture performed on BM. Leishmania DNA was cleared from PB a median of 6 days after the start of treatment; during follow-up (median: 9 months; range: 6-12 months) 1 child relapsed. In this case, BM PCR remained positive with rapid reappearance of a positive signal also in PB.
CONCLUSIONS:
PB PCR allows a rapid and noninvasive parasitologic diagnosis of Mediterranean VL among immunocompetent children and is at least as sensitive as a diagnosis made on the basis of BM aspirates. The lack of disappearance from BM and the reappearance of positive PCR on PB is predictive of clinical relapse. Qualitative and semiquantitative PCR may be the standard method for monitoring response to therapy in immunocompetent childre
A 6 day course of liposomal amphotericin B in the treatment of infantile visceral leishmaniasis: the Italian experience
OBJECTIVES: To evaluate in a retrospective analysis the efficacy and safety of a 6 day course of liposomal amphotericin B (L-AmB) in infantile cases of Mediterranean visceral leishmaniasis (VL) diagnosed over a 10 year period in Italy.
PATIENTS AND METHODS: Patients included were diagnosed as having VL consecutively admitted from December 1992 to December 2001 at four main referral children's hospitals in Italy and treated with six intravenous doses of 3 mg/kg L-AmB given on days 1-5 and 10 (a total dose of 18 mg/kg). Demographic data, nutritional status, underlying diseases, clinical and laboratory findings, and therapy outcome were considered.
RESULTS: A total of 164 HIV-negative children (median age 1.6 years; range 4 months to 14 years) were enrolled. All patients were initially cured by the given treatment, and did not present adverse events related to drug infusion. Seven patients (4.3%) had a clinical and parasitological relapse 3-15 months after therapy. All relapses were successfully retreated with 3 mg/kg L-AmB for 10 consecutive days (a total dose of 30 mg/kg).
CONCLUSIONS: This study highlights the efficacy (>95%) and safety of the six dose L-AmB regimen and validates it as a first-line treatment for Mediterranean VL in children
Clinical use of polymerase chain reaction performed on peripheral blood and bone marrow samples for the diagnosis and monitoring of visceral leishmaniasis in HIV-infected and HIV-uninfected patients: a single-center, 8-year experience in Italy and review of the literature
Background. To overcome some of the limitations of conventional microbiologic techniques, polymerase chain
reaction (PCR)–based assays are proposed as useful tools for the diagnosis of visceral leishmaniasis.
Patients and methods. A comparative study using conventional microbiologic techniques (i.e., serologic testing,
microscopic examination, and culture) and a Leishmania species–specific PCR assay, using peripheral blood and
bone marrow aspirate samples as templates, was conducted during an 8-year period. The study cohort consisted
of 594 Italian immunocompetent (adult and pediatric) and immunocompromised (adult) patients experiencing
febrile syndromes associated with hematologic alterations and/or hepatosplenomegaly. Identification of the infecting
protozoa at the species level was directly obtained by PCR of peripheral blood samples, followed by restriction
fragment–length polymorphism analysis of the amplified products, and the results were compared with those of
isoenzyme typing of Leishmania species strains from patients, which were isolated in vitro.
Results. Sixty-eight patients (11.4%) had a confirmed diagnosis of visceral leishmaniasis. Eleven cases were
observed in human immunodeficiency virus (HIV)–uninfected adults, 20 cases were observed in HIV-infected
adults, and the remaining 37 cases were diagnosed in HIV-uninfected children. In the diagnosis of primary visceral
leishmaniasis, the sensitivities of the Leishmania species–specific PCR were 95.7% for bone marrow aspirate samples
and 98.5% for peripheral blood samples versus sensitivities of 76.2%, 85.5%, and 90.2% for bone marrow aspirate
isolation, serologic testing, and microscopic examination of bone marrow biopsy specimens, respectively. None of
229 healthy blood donors or 25 patients with imported malaria who were used as negative control subjects had
PCR results positive for Leishmania species in peripheral blood samples (i.e., specificity of Leishmania species–
specific PCR, 100%). PCR and restriction fragment–length polymorphism analysis for Leishmania species identification
revealed 100% concordance with isoenzyme typing in the 19 patients for whom the latter data were
available.
Conclusions. PCR assay is a highly sensitive and specific tool for the diagnosis of visceral leishmaniasis in both
immunocompetent and immunocompromised patients and can be reliably used for rapid parasite identification
at the species level
Time-series analysis of abundance indices of deep sea resources in the Strait of Sicily
Time-series of abundance indices of deep sea demersal resources (501-800m) derived by the MEDITS trawl survey in the Strait of Sicily (GSA 16) were analysed by aggregated taxa (bony fish, cartilaginous fish, cephalopods and crustaceans) and species using a polynomial approach. The results showed a significant increasing trend of the cartilaginous fish and cephalopods, in terms of biomass (kg/km) and density (n/Km) indices, whereas temporal pattern in bony fish and crustaceans resulted not significant. Helicolenus dactylopterus, Hoplostetus mediterraneus, Galeus melastomus, Nephrops norvegicus and Aristaeomorpha foliacea showed significant trends in both number and weight, whereas Aristeus antennatus, Etmopterus spinax and Chimera monstrosa only in biomass.This work was carried out within the Data Collection Regulation and Framework - module trawl surveys MEDITS funded by European Union and the Italian Ministry of Agricultural, Food and Forestry Policies.peer-reviewe
Puzzling over spurdogs : molecular taxonomy assessment of the Squalus species in the Strait of Sicily
The actual occurrence of Squalus megalops in the Mediterranean Sea has recently been questioned. Several research works
which sought to assess available morphological and meristic features that differentiate S. megalops from other Squalus species in
the Mediterranean Sea, revealed poor discriminatory power and high variability of the assessed characters, especially when
comparing S. megalops and S. blainville. The application of molecular tools does not support the presence of S. megalops.
In the present study, we screened spurdog species from the Strait of Sicily using a molecular taxonomy approach based
on two mitochondrial DNA markers and we report the occurrence of two Squalus lineages characterizing specimens
collected from the stretch of sea between Tunisia, southern Sicily, Malta and Libya. The results support the hypothesis
that a common species, S. blainville, currently inhabits the Mediterranean Sea, while a second and rare species is probably
an occasional visitor with high morphological similarity to the S. megalops and S. blainville but is genetically distinct from
both. Within this perspective, the occurrence of S. megalops in the Mediterranean Sea is not confirmed and our study
highlights the taxonomic uncertainties in relation to the occurrence and distribution of Squalus species in this region. We
encourage the establishment of a coordinated international effort to implement a comprehensive and integrated taxonomic
assessment on this genus which represents an irreplaceable component of the biodiversity of the area.peer-reviewe
Effect of Moisture Content on the Processing and Mechanical Properties of a Biodegradable Polyester
This work is focused on the influence of moisture content on the processing and mechanical properties of a biodegradable polyester used for applications in injection molding. The pellets of the biodegradable polyester were exposed under different relative humidity conditions at a constant temperature before being compression molded. The compression-molded specimens were again placed under the above conditions before the mechanical testing. With all these samples, it is possible to determine the effect of moisture content on the processing and mechanical properties separately, as well as the combined effect of moisture content on the mechanical properties. The results obtained showed that the amount of absorbed water—both before processing and before mechanical testing—causes an increase in elongation at break and a slight reduction of the elastic modulus and tensile strength. These changes have been associated with possible hydrolytic degradation during the compression molding process and, in particular, with the plasticizing action of the moisture absorbed by the specimens
Clarithromycin versus azithromycin in the treatment of Mediterranean spotted fever in children: A randomized controlled trial
We conducted an open-label randomized controlled trial to compare the efficacy and safety of clarithromycin (15/mg/kg/day in 2 divided doses for 7 days) with those of azithromycin (10 mg/kg/day in 1 dose for 3 days) in the treatment of children with Mediterranean spotted fever. Until now, there has not been a gold-standard therapy for this rickettsial disease in children. Eighty-seven children were randomized to receive 1 of the 2 drugs. The mean time to defervescence (± standard deviation) was 46.2 ± 36.4 h in the clarithromycin group and 39.3 ± 31.3 h in the azithromycin group. These differences were not statistically significant and both drugs were equally well-tolerated. Clarithromycin and azithromycin could be acceptable therapeutic alternatives to chloramphenicol and tetracyclines for children aged ≤8 years with Mediterranean spotted fever. Azithromycin, because it has a long half-life, offers the advantages of administration in a single daily dose and a shorter duration of therapy, which could increase compliance in children